INmune Bio(INMB) - 2025 Q1 - Earnings Call Transcript
INmune Bio (INMB) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Company Participants David Moss - Chief Financial OfficerRaymond Tesi - CEO & ChairmanMark Lowdell - Chief Scientific Officer & Chief Manufacturing OfficerDenis Reznik - Senior Equity Research AssociateChristopher Barnum - VP - NeuroscienceGeorge Farmer - Managing DirectorLaura Suriel - Equity Research Associate Conference Call Participants Thomas Shrader - MD & Healthcare Analyst Operator Greetings, and welcome to the Immune Bio First Quarter ...